IMI is a Public-Private Partnership initiative, aimed at improving health by speeding up the development of, and patient access to innovative medicines, particularly in areas where there is an unmet medical or social need, and by facilitating collaboration between the key players involved in health research. Citizens are invited to participate in the PP IMI by becoming a partner in a project or member of project advisory committees or associate partner or by proposing ideas and suggestions. IMI launches calls for proposals and publishes draft topics texts on future topics. The calls require the participation of citizen and patient organisations.
Part of interest: See the general overview and the call documents.
Target groups: RPOs, Innovation business, Policymakers, CSOs, Patients, Payers, Providers, Professionals, Intermediaries